Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Clinical trial NCT01867294 · COMPLETED
Trial details
- NCT number
- NCT01867294
- Sponsor
- Academic and Community Cancer Research United
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-31
- Primary completion
- 2014-05-09
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.